326 Optimization of GPRC5D-targeted CAR T cells (OriCAR-017) for multiple myeloma

• Yuting Zhang,
• Jincai Zhou,
• Zhongjun Shi,
• Feifei Shi,
• Siye Chen,
• Chenyu Huang,
• Huijiao Li,
• Ruirong Yi,
• Huajing Wang,
• Xian-Yang Li,
• Xiaowen He

Affiliations

Yuting Zhang

Oricell Therapeutics, Shanghai, China

Jincai Zhou

Oricell Therapeutics, Shanghai, China

Zhongjun Shi

Oricell Therapeutics, Shanghai, China

Feifei Shi

Oricell Therapeutics, Shanghai, China

Siye Chen

Oricell Therapeutics, Shanghai, China

Chenyu Huang

Oricell Therapeutics, Shanghai, China

Huijiao Li

Oricell Therapeutics, Shanghai, China

Ruirong Yi

Oricell Therapeutics, Shanghai, China

Huajing Wang

Oricell Therapeutics, Shanghai, China

Xian-Yang Li

Oricell Therapeutics, Shanghai, China

Xiaowen He

Oricell Therapeutics, Shanghai, China